Document is current
Any future updates will be listed below
-
Authors
Brändl, Björn https://orcid.org/0000-0003-1044-1355
Steiger, Mara https://orcid.org/0000-0002-3747-685X
Kubelt, Carolin
Rohrandt, Christian
Zhu, Zhihan https://orcid.org/0000-0003-3779-4265
Evers, Maximilian
Wang, Gaojianyong
Schuldt, Bernhard
Afflerbach, Ann-Kristin
Wong, Derek
Lum, Amy
Halldorsson, Skarphedinn
Djirackor, Luna
Leske, Henning
Magadeeva, Svetlana
Smičius, Romualdas
Quedenau, Claudia https://orcid.org/0000-0002-6846-4915
Schmidt, Nils O.
Schüller, Ulrich https://orcid.org/0000-0002-8731-1121
Vik-Mo, Einar O. https://orcid.org/0000-0001-8303-4123
Proescholdt, Martin
Riemenschneider, Markus J.
Zadeh, Gelareh https://orcid.org/0000-0002-6637-4502
Ammerpohl, Ole
Yip, Stephen https://orcid.org/0000-0002-8514-9861
Synowitz, Michael
van Bömmel, Alena https://orcid.org/0000-0002-8434-8586
Kretzmer, Helene https://orcid.org/0000-0002-0723-4980
Müller, Franz-Josef https://orcid.org/0000-0001-9478-8430
-
Funding
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (13GW0347C)
Bundesministerium für Bildung und Forschung (13GW0347C)
Bundesministerium für Bildung und Forschung (13GW0347C)
Bundesministerium für Bildung und Forschung (13GW0347D)
Bundesministerium für Bildung und Forschung (13GW0347D)
Bundesministerium für Bildung und Forschung (13GW0347A)
- License Information
-
More Information
Article History
Received: 7 February 2024
Accepted: 27 November 2024
First Online: 28 February 2025
Competing interests
: F.-J.M., B.S., H.K., A.v.B., B.B. and C.R. filed a patent application (WO 2023/031485 A1) covering the development of MethyLYZR. S.Y. is a member of advisory boards and has received honoraria from Amgen, AstraZeneca, Bayer, Janssen, Roche and Servier. H.K. is a member of an expert panel and has received honoraria from Roche and Oxford Nanopore Technologies. The remaining authors declare no competing interests.
